Selection of Elderly Acute Myeloid Leukemia Patients for Intensive Chemotherapy: Effectiveness of Intensive Chemotherapy and Subgroup Analysis

Publisher： Karger

E-ISSN： 1421-9662|133|3|300-309

ISSN： 0001-5792

Source： Acta Haematologica, Vol.133, Iss.3, 2014-12, pp. : 300-309

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Azacitidine in elderly AML

By  

ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, Vol. 11, Iss. 1, 2015-03 ,pp. : 54-61

John Wiley & Sons Inc

Access to resources Recommend Favorite

Post‐remission intensive treatment after induction chemotherapy is feasible in selected elderly patients with acute myeloid leukemia and age ≥75 years: A retrospective analysis of the Rete Ematologica Lombarda

By  

AMERICAN JOURNAL OF HEMATOLOGY, Vol. 90, Iss. 6, 2015-06 ,pp. : E123-E125

John Wiley & Sons Inc

Access to resources Recommend Favorite

High-Intensity Induction Chemotherapy Is Feasible for Elderly Patients with Acute Myeloid Leukemia

By  

Acta Haematologica, Vol. 135, Iss. 1, 2015-0 ,pp. : 55-64

Karger

Access to resources Recommend Favorite

Outpatient Management of Acute Myeloid Leukemia after Intensive Consolidation Chemotherapy Is Feasible and Reduces Hospital Treatment Costs

By  

Oncology Research and Treatment, Vol. 33, Iss. 12, 2010-11 ,pp. : 658-664

Karger

Access to resources Recommend Favorite

A phase I/II study of sunitinib and intensive chemotherapy in patients over 60 years of age with acute myeloid leukaemia and activating FLT3 mutations

By  

BRITISH JOURNAL OF HAEMATOLOGY, Vol. 169, Iss. 5, 2015-06 ,pp. : 694-700

John Wiley & Sons Inc

Access to resources Recommend Favorite